Pharmacologic treatments for covid-19 patients
Ivermectin 12 mg vs Ivermectin 24 mg
This comparison will not be updated. Last search date 28 Feb, 2022.
Hospitalized patients
Forest plots
(last update: 2021-02-18)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=255
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| CTRI/2020/06/026001 RIVET-COV Mohan A, J Infect Chemother, 2021 Full text Full text Commentary |
Mixed |
Ivermectin 12 mg Ivermectin 24 mg Ivermectin 12 mg |
Placebo Placebo Ivermectin 24 mg |
RCT | Patients with confirmed COVID-19 (asymptomatic-mild-moderate) admitted to a single center in India | N=157 |
Some concerns Details |
|